 | • レポートコード：MRC2-11QY04198 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は小児用医薬品のグローバル市場について調査・分析したレポートです。種類別（経腸、非経口）市場規模、用途別（呼吸器疾患、感染症、胃腸疾患、中枢神経系疾患、腫瘍性疾患、CVD、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別小児用医薬品の競争状況、市場シェア ・世界の小児用医薬品市場：種類別市場規模 2015年-2020年（経腸、非経口） ・世界の小児用医薬品市場：種類別市場規模予測 2021年-2026年（経腸、非経口） ・世界の小児用医薬品市場：用途別市場規模 2015年-2020年（呼吸器疾患、感染症、胃腸疾患、中枢神経系疾患、腫瘍性疾患、CVD、その他） ・世界の小児用医薬品市場：用途別市場規模予測 2021年-2026年（呼吸器疾患、感染症、胃腸疾患、中枢神経系疾患、腫瘍性疾患、CVD、その他） ・北米の小児用医薬品市場分析：米国、カナダ ・ヨーロッパの小児用医薬品市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの小児用医薬品市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の小児用医薬品市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの小児用医薬品市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GSK、Novartis、Pfizer、Sanofi、Abbott、Bristol-Myers Squibb、Cipla、Eisai Pharmaceuticals、Eli Lilly、F. Hoffman-La Roche、Glenmark、Helsinn Healthcare、Heron Therapeutics、Ipca Laboratories、Lupin Pharmaceuticals、Merck Sharp & Dohme、RedHill、Sun Pharmaceutical Industries、Takeda Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Pediatrics (also spelled paediatrics or pædiatrics) is the branch of medicine that involves the medical care of infants, children, and adolescents.This report anzlyed the medicines for pediatrics.
Market Analysis and Insights: Global Pediatrics Medicine Market
The global Pediatrics Medicine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Pediatrics Medicine Scope and Market Size
Pediatrics Medicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pediatrics Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GSK
Novartis
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai Pharmaceuticals
Eli Lilly
F. Hoffman-La Roche
Glenmark
Helsinn Healthcare
Heron Therapeutics
Ipca Laboratories
Lupin Pharmaceuticals
Merck Sharp & Dohme
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Market segment by Type, the product can be split into
Enteral
Parenteral
Market segment by Application, split into
Respiratory diseases
Infectious diseases
Gastrointestinal diseases
CNS diseases
Oncological diseases
CVDs
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pediatrics Medicine Revenue
1.4 Market by Type
1.4.1 Global Pediatrics Medicine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Enteral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Pediatrics Medicine Market Share by Application: 2020 VS 2026
1.5.2 Respiratory diseases
1.5.3 Infectious diseases
1.5.4 Gastrointestinal diseases
1.5.5 CNS diseases
1.5.6 Oncological diseases
1.5.7 CVDs
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pediatrics Medicine Market Perspective (2015-2026)
2.2 Global Pediatrics Medicine Growth Trends by Regions
2.2.1 Pediatrics Medicine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pediatrics Medicine Historic Market Share by Regions (2015-2020)
2.2.3 Pediatrics Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pediatrics Medicine Market Growth Strategy
2.3.6 Primary Interviews with Key Pediatrics Medicine Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pediatrics Medicine Players by Market Size
3.1.1 Global Top Pediatrics Medicine Players by Revenue (2015-2020)
3.1.2 Global Pediatrics Medicine Revenue Market Share by Players (2015-2020)
3.1.3 Global Pediatrics Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pediatrics Medicine Market Concentration Ratio
3.2.1 Global Pediatrics Medicine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pediatrics Medicine Revenue in 2019
3.3 Pediatrics Medicine Key Players Head office and Area Served
3.4 Key Players Pediatrics Medicine Product Solution and Service
3.5 Date of Enter into Pediatrics Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pediatrics Medicine Historic Market Size by Type (2015-2020)
4.2 Global Pediatrics Medicine Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pediatrics Medicine Market Size by Application (2015-2020)
5.2 Global Pediatrics Medicine Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pediatrics Medicine Market Size (2015-2020)
6.2 Pediatrics Medicine Key Players in North America (2019-2020)
6.3 North America Pediatrics Medicine Market Size by Type (2015-2020)
6.4 North America Pediatrics Medicine Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pediatrics Medicine Market Size (2015-2020)
7.2 Pediatrics Medicine Key Players in Europe (2019-2020)
7.3 Europe Pediatrics Medicine Market Size by Type (2015-2020)
7.4 Europe Pediatrics Medicine Market Size by Application (2015-2020)
8 China
8.1 China Pediatrics Medicine Market Size (2015-2020)
8.2 Pediatrics Medicine Key Players in China (2019-2020)
8.3 China Pediatrics Medicine Market Size by Type (2015-2020)
8.4 China Pediatrics Medicine Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pediatrics Medicine Market Size (2015-2020)
9.2 Pediatrics Medicine Key Players in Japan (2019-2020)
9.3 Japan Pediatrics Medicine Market Size by Type (2015-2020)
9.4 Japan Pediatrics Medicine Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pediatrics Medicine Market Size (2015-2020)
10.2 Pediatrics Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pediatrics Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Pediatrics Medicine Market Size by Application (2015-2020)
11 India
11.1 India Pediatrics Medicine Market Size (2015-2020)
11.2 Pediatrics Medicine Key Players in India (2019-2020)
11.3 India Pediatrics Medicine Market Size by Type (2015-2020)
11.4 India Pediatrics Medicine Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pediatrics Medicine Market Size (2015-2020)
12.2 Pediatrics Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Pediatrics Medicine Market Size by Type (2015-2020)
12.4 Central & South America Pediatrics Medicine Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GSK
13.1.1 GSK Company Details
13.1.2 GSK Business Overview
13.1.3 GSK Pediatrics Medicine Introduction
13.1.4 GSK Revenue in Pediatrics Medicine Business (2015-2020))
13.1.5 GSK Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Pediatrics Medicine Introduction
13.2.4 Novartis Revenue in Pediatrics Medicine Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Pediatrics Medicine Introduction
13.3.4 Pfizer Revenue in Pediatrics Medicine Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Sanofi
13.4.1 Sanofi Company Details
13.4.2 Sanofi Business Overview
13.4.3 Sanofi Pediatrics Medicine Introduction
13.4.4 Sanofi Revenue in Pediatrics Medicine Business (2015-2020)
13.4.5 Sanofi Recent Development
13.5 Abbott
13.5.1 Abbott Company Details
13.5.2 Abbott Business Overview
13.5.3 Abbott Pediatrics Medicine Introduction
13.5.4 Abbott Revenue in Pediatrics Medicine Business (2015-2020)
13.5.5 Abbott Recent Development
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Details
13.6.2 Bristol-Myers Squibb Business Overview
13.6.3 Bristol-Myers Squibb Pediatrics Medicine Introduction
13.6.4 Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2015-2020)
13.6.5 Bristol-Myers Squibb Recent Development
13.7 Cipla
13.7.1 Cipla Company Details
13.7.2 Cipla Business Overview
13.7.3 Cipla Pediatrics Medicine Introduction
13.7.4 Cipla Revenue in Pediatrics Medicine Business (2015-2020)
13.7.5 Cipla Recent Development
13.8 Eisai Pharmaceuticals
13.8.1 Eisai Pharmaceuticals Company Details
13.8.2 Eisai Pharmaceuticals Business Overview
13.8.3 Eisai Pharmaceuticals Pediatrics Medicine Introduction
13.8.4 Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020)
13.8.5 Eisai Pharmaceuticals Recent Development
13.9 Eli Lilly
13.9.1 Eli Lilly Company Details
13.9.2 Eli Lilly Business Overview
13.9.3 Eli Lilly Pediatrics Medicine Introduction
13.9.4 Eli Lilly Revenue in Pediatrics Medicine Business (2015-2020)
13.9.5 Eli Lilly Recent Development
13.10 F. Hoffman-La Roche
13.10.1 F. Hoffman-La Roche Company Details
13.10.2 F. Hoffman-La Roche Business Overview
13.10.3 F. Hoffman-La Roche Pediatrics Medicine Introduction
13.10.4 F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2015-2020)
13.10.5 F. Hoffman-La Roche Recent Development
13.11 Glenmark
10.11.1 Glenmark Company Details
10.11.2 Glenmark Business Overview
10.11.3 Glenmark Pediatrics Medicine Introduction
10.11.4 Glenmark Revenue in Pediatrics Medicine Business (2015-2020)
10.11.5 Glenmark Recent Development
13.12 Helsinn Healthcare
10.12.1 Helsinn Healthcare Company Details
10.12.2 Helsinn Healthcare Business Overview
10.12.3 Helsinn Healthcare Pediatrics Medicine Introduction
10.12.4 Helsinn Healthcare Revenue in Pediatrics Medicine Business (2015-2020)
10.12.5 Helsinn Healthcare Recent Development
13.13 Heron Therapeutics
10.13.1 Heron Therapeutics Company Details
10.13.2 Heron Therapeutics Business Overview
10.13.3 Heron Therapeutics Pediatrics Medicine Introduction
10.13.4 Heron Therapeutics Revenue in Pediatrics Medicine Business (2015-2020)
10.13.5 Heron Therapeutics Recent Development
13.14 Ipca Laboratories
10.14.1 Ipca Laboratories Company Details
10.14.2 Ipca Laboratories Business Overview
10.14.3 Ipca Laboratories Pediatrics Medicine Introduction
10.14.4 Ipca Laboratories Revenue in Pediatrics Medicine Business (2015-2020)
10.14.5 Ipca Laboratories Recent Development
13.15 Lupin Pharmaceuticals
10.15.1 Lupin Pharmaceuticals Company Details
10.15.2 Lupin Pharmaceuticals Business Overview
10.15.3 Lupin Pharmaceuticals Pediatrics Medicine Introduction
10.15.4 Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020)
10.15.5 Lupin Pharmaceuticals Recent Development
13.16 Merck Sharp & Dohme
10.16.1 Merck Sharp & Dohme Company Details
10.16.2 Merck Sharp & Dohme Business Overview
10.16.3 Merck Sharp & Dohme Pediatrics Medicine Introduction
10.16.4 Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2015-2020)
10.16.5 Merck Sharp & Dohme Recent Development
13.17 RedHill
10.17.1 RedHill Company Details
10.17.2 RedHill Business Overview
10.17.3 RedHill Pediatrics Medicine Introduction
10.17.4 RedHill Revenue in Pediatrics Medicine Business (2015-2020)
10.17.5 RedHill Recent Development
13.18 Sun Pharmaceutical Industries
10.18.1 Sun Pharmaceutical Industries Company Details
10.18.2 Sun Pharmaceutical Industries Business Overview
10.18.3 Sun Pharmaceutical Industries Pediatrics Medicine Introduction
10.18.4 Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2015-2020)
10.18.5 Sun Pharmaceutical Industries Recent Development
13.19 Takeda Pharmaceutical
10.19.1 Takeda Pharmaceutical Company Details
10.19.2 Takeda Pharmaceutical Business Overview
10.19.3 Takeda Pharmaceutical Pediatrics Medicine Introduction
10.19.4 Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2015-2020)
10.19.5 Takeda Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Pediatrics Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by Pediatrics Medicine Revenue
Table 3. Ranking of Global Top Pediatrics Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pediatrics Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Enteral
Table 6. Key Players of Parenteral
Table 7. Global Pediatrics Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Pediatrics Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Pediatrics Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Pediatrics Medicine Market Share by Regions (2015-2020)
Table 11. Global Pediatrics Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Pediatrics Medicine Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Pediatrics Medicine Market Growth Strategy
Table 17. Main Points Interviewed from Key Pediatrics Medicine Players
Table 18. Global Pediatrics Medicine Revenue by Players (2015-2020) (Million US$)
Table 19. Global Pediatrics Medicine Market Share by Players (2015-2020)
Table 20. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatrics Medicine as of 2019)
Table 21. Global Pediatrics Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pediatrics Medicine Product Solution and Service
Table 24. Date of Enter into Pediatrics Medicine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 27. Global Pediatrics Medicine Market Size Share by Type (2015-2020)
Table 28. Global Pediatrics Medicine Revenue Market Share by Type (2021-2026)
Table 29. Global Pediatrics Medicine Market Size Share by Application (2015-2020)
Table 30. Global Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 31. Global Pediatrics Medicine Market Size Share by Application (2021-2026)
Table 32. North America Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Pediatrics Medicine Market Share (2019-2020)
Table 34. North America Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 35. North America Pediatrics Medicine Market Share by Type (2015-2020)
Table 36. North America Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 37. North America Pediatrics Medicine Market Share by Application (2015-2020)
Table 38. Europe Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Pediatrics Medicine Market Share (2019-2020)
Table 40. Europe Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Pediatrics Medicine Market Share by Type (2015-2020)
Table 42. Europe Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Pediatrics Medicine Market Share by Application (2015-2020)
Table 44. China Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 45. China Key Players Pediatrics Medicine Market Share (2019-2020)
Table 46. China Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 47. China Pediatrics Medicine Market Share by Type (2015-2020)
Table 48. China Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 49. China Pediatrics Medicine Market Share by Application (2015-2020)
Table 50. Japan Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Pediatrics Medicine Market Share (2019-2020)
Table 52. Japan Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Pediatrics Medicine Market Share by Type (2015-2020)
Table 54. Japan Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Pediatrics Medicine Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Pediatrics Medicine Market Share (2019-2020)
Table 58. Southeast Asia Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Pediatrics Medicine Market Share by Type (2015-2020)
Table 60. Southeast Asia Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Pediatrics Medicine Market Share by Application (2015-2020)
Table 62. India Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 63. India Key Players Pediatrics Medicine Market Share (2019-2020)
Table 64. India Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 65. India Pediatrics Medicine Market Share by Type (2015-2020)
Table 66. India Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 67. India Pediatrics Medicine Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Pediatrics Medicine Market Share (2019-2020)
Table 70. Central & South America Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Pediatrics Medicine Market Share by Type (2015-2020)
Table 72. Central & South America Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Pediatrics Medicine Market Share by Application (2015-2020)
Table 74. GSK Company Details
Table 75. GSK Business Overview
Table 76. GSK Product
Table 77. GSK Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 78. GSK Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Product
Table 82. Novartis Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 83. Novartis Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Product
Table 87. Pfizer Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 88. Pfizer Recent Development
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi Product
Table 92. Sanofi Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 93. Sanofi Recent Development
Table 94. Abbott Company Details
Table 95. Abbott Business Overview
Table 96. Abbott Product
Table 97. Abbott Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 98. Abbott Recent Development
Table 99. Bristol-Myers Squibb Company Details
Table 100. Bristol-Myers Squibb Business Overview
Table 101. Bristol-Myers Squibb Product
Table 102. Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 103. Bristol-Myers Squibb Recent Development
Table 104. Cipla Company Details
Table 105. Cipla Business Overview
Table 106. Cipla Product
Table 107. Cipla Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 108. Cipla Recent Development
Table 109. Eisai Pharmaceuticals Business Overview
Table 110. Eisai Pharmaceuticals Product
Table 111. Eisai Pharmaceuticals Company Details
Table 112. Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 113. Eisai Pharmaceuticals Recent Development
Table 114. Eli Lilly Company Details
Table 115. Eli Lilly Business Overview
Table 116. Eli Lilly Product
Table 117. Eli Lilly Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 118. Eli Lilly Recent Development
Table 119. F. Hoffman-La Roche Company Details
Table 120. F. Hoffman-La Roche Business Overview
Table 121. F. Hoffman-La Roche Product
Table 122. F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 123. F. Hoffman-La Roche Recent Development
Table 124. Glenmark Company Details
Table 125. Glenmark Business Overview
Table 126. Glenmark Product
Table 127. Glenmark Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 128. Glenmark Recent Development
Table 129. Helsinn Healthcare Company Details
Table 130. Helsinn Healthcare Business Overview
Table 131. Helsinn Healthcare Product
Table 132. Helsinn Healthcare Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 133. Helsinn Healthcare Recent Development
Table 134. Heron Therapeutics Company Details
Table 135. Heron Therapeutics Business Overview
Table 136. Heron Therapeutics Product
Table 137. Heron Therapeutics Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 138. Heron Therapeutics Recent Development
Table 139. Ipca Laboratories Company Details
Table 140. Ipca Laboratories Business Overview
Table 141. Ipca Laboratories Product
Table 142. Ipca Laboratories Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 143. Ipca Laboratories Recent Development
Table 144. Lupin Pharmaceuticals Company Details
Table 145. Lupin Pharmaceuticals Business Overview
Table 146. Lupin Pharmaceuticals Product
Table 147. Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 148. Lupin Pharmaceuticals Recent Development
Table 149. Merck Sharp & Dohme Company Details
Table 150. Merck Sharp & Dohme Business Overview
Table 151. Merck Sharp & Dohme Product
Table 152. Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 153. Merck Sharp & Dohme Recent Development
Table 154. RedHill Company Details
Table 155. RedHill Business Overview
Table 156. RedHill Product
Table 157. RedHill Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 158. RedHill Recent Development
Table 159. Sun Pharmaceutical Industries Company Details
Table 160. Sun Pharmaceutical Industries Business Overview
Table 161. Sun Pharmaceutical Industries Product
Table 162. Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 163. Sun Pharmaceutical Industries Recent Development
Table 164. Takeda Pharmaceutical Company Details
Table 165. Takeda Pharmaceutical Business Overview
Table 166. Takeda Pharmaceutical Product
Table 167. Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 168. Takeda Pharmaceutical Recent Development
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatrics Medicine Market Share by Type: 2020 VS 2026
Figure 2. Enteral Features
Figure 3. Parenteral Features
Figure 4. Global Pediatrics Medicine Market Share by Application: 2020 VS 2026
Figure 5. Respiratory diseases Case Studies
Figure 6. Infectious diseases Case Studies
Figure 7. Gastrointestinal diseases Case Studies
Figure 8. CNS diseases Case Studies
Figure 9. Oncological diseases Case Studies
Figure 10. CVDs Case Studies
Figure 11. Others Case Studies
Figure 12. Pediatrics Medicine Report Years Considered
Figure 13. Global Pediatrics Medicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Pediatrics Medicine Market Share by Regions: 2020 VS 2026
Figure 15. Global Pediatrics Medicine Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Pediatrics Medicine Market Share by Players in 2019
Figure 18. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatrics Medicine as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Pediatrics Medicine Revenue in 2019
Figure 20. North America Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
POC感染性疾患の世界市場（～2026年） POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care. Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted peri…- 感染症の世界市場（～2026年） When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antip…
- 希少疾患の世界市場（～2026年） An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or "gigantism." Some diseases hav…
- 運動ニューロン疾患治療の世界市場（～2026年） Market Analysis and Insights: Global Motor Neuron Diseases Treatment Market The global Motor Neuron Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Motor Neuron Diseases Treatment Scope and Market Si…
- 動物用自己免疫疾患検査の世界市場（～2026年） Animal autoimmune diseases are the result of specific immune responses and directed against self. Animals have the ability to control immune aggression. It acquired the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition…